Spectralis
Multimodal Imaging Platform Optimized for the Posterior Segment
The SPECTRALIS® is an ophthalmic imaging platform with an upgradable, modular design. This platform allows clinicians to configure each SPECTRALIS to the specific diagnostic workflow in the practice or clinic.
Multimodal imaging options include: OCT, multiple scanning laser fundus imaging modalities, widefield and ultra-widefield, scanning laser angiography and OCT angiography.
The DNA of SPECTRALIS:
SPECTRALIS® is a truly flexible and upgradeable imaging platform. Customize your SPECTRALIS precisely to your individual needs, confident in the knowledge that your OCT will grow with your clinic. As new technology becomes available, simply add new imaging modalities to your SPECTRALIS, providing you with additional information to enhance clinical decision-making and preserving patient data for precise follow-up.
The confocal scanning laser ophthalmoscope (cSLO) in the SPECTRALIS® platform is an innovative technology for examining and imaging the retina and other eye structures. Combining the selectivity of laser light with the pinpoint resolution of confocal scanning, the cSLO provides image detail and clarity not available from fundus photography. The cSLO technology not only offers documentation of clinical findings but also often highlights critical diagnostic details not visible on traditional clinical ophthalmoscopy. Since cSLO imaging minimizes the effects of light scatter, it can be used effectively even in patients with cataracts.
The unique combination of imaging modalities provides the additional information you need to make confident clinical decisions. Use different, established and novel imaging techniques simultaneously to improve your understanding of different pathologies.
TruTrack Active Eye Tracking is a patented imaging technology that utilizes two beams of light simultaneously to track and image the eye. Actively tracking the eye in real-time throughout image capture, mitigates the effects of eye motion, resulting in accurate OCT scan data. Additional clinical benefits of TruTrack Active Eye Tracking are precise, automated retinal follow-up scanning, retinal thickness measurement reproducibility to 1 micron, and excellent image quality throughout the volume scan.This superior performance allows a more effective management of patients, even in challenging cases with very small changes over time.
Using the SPECTRALIS® fundus image like a map, the AutoRescan function automatically places follow-up scans in precisely the same position visit after visit. Accurate, automatic placement of follow-up scans is important for optimizing patient flow and for confident recognition of the small structural changes that are critical to the effective management of many ophthalmic conditions. Studies have shown that SPECTRALIS with AutoRescan technology can reliably measure changes in retinal thickness as small as 1 micron.
SPECTRALIS® Noise Reduction is a proprietary technology that removes noise inherent in OCT and scanning laser imaging. By capturing multiple images in the exact same location this technology is able to differentiate structural information from noise and then effectively remove noise. The resulting images from vitreous through choroid and across the entire posterior pole are of high contrast and exceptional detail.
SPECTRALIS® provides you with high resolution OCT images for visualization of 10 retinal layers, to help you confidently describe and pinpoint pathology.
The of SPECTRALIS module :
Curious to know more about our products ? Have a look on here…
HRT3 RCM
In vivo corneal confocal microscope
HRT3 RCM is a compact ophthalmic device that uses confocal scanning laser microscopy to provide high-resolution images of the cornea and external ocular structures, such as the conjunctiva or the limbus.
Scanning the cornea with a field of view of up to 400 x 400 μm, HRT3 RCM allows you to acquire unique en face images of corneal cells and structures, identify keratocytes subpopulations, and visualize details of the corneal subbasal nerve plexus.
Navigate through the cornea at the cellular level and select your preferred scanning depth for a comprehensive in vivo assessment of all corneal layers – from epithelium to endothelium.
The comprehensive assessment of the cornea and other external ocular structures with HRT3 RCM can aid you in the diagnosis and monitoring of corneal abnormalities, pre- and post-surgery evaluation, the assessment of dry eye disease, or in the analysis of corneal nerve structure in diabetic patients.
Features:
- Epithelium – 30 μm
- Corneal Subbasal Nerve Plexus – 62 μm
- Stroma – 300 μm
- Endothelium – 572 μm
- Customized acquisition modes
- HRT3 RCM lets you choose the acquisition mode that fits your clinical needs.
Curious to know more about our products ? Have a look on here…